Cited by 141Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

EFNS task force: the use of neuroimaging in the diagnosis of dementia

Open access
Filippi, M., Agosta, F., Barkhof, F., Dubois, B., Fox, N. C., Frisoni, G. B., Jack, C. R., Johannsen, P. +7 more·2012·European Journal of Neurology

Abstract

Background and purpose: The E uropean F ederation of the N eurological S ocieties (EFNS) guidelines on the use of neuroimaging in the diagnosis and management of dementia are designed to revise and expand previous EFNS recommendations for the diagnosis and management of patients with A lzheimer's disease (AD) and to provide an overview of the evidence for the use of neuroimaging techniques in non‐AD dementias, as well as general recommendations that apply to all types of dementia in clinical practice. Methods: The task force working group reviewed evidence from original research articles, meta‐analyses and systematic reviews, published before A pril 2012. The evidence was classified, and consensus recommendations were given and graded according to the EFNS guidance regulations. Results: Structural imaging, which should be performed at least once in the diagnostic work‐up of patients with cognitive impairment, serves to exclude other potentially treatable diseases, to recognize vascular lesions and to identify specific findings to help distinguish different forms of neurodegenerative types of dementia. Although typical cases of dementia may not benefit from routine functional imaging, these tools are recommended in those cases where diagnosis remains in doubt after clinical and structural imaging work‐up and in particular clinical settings. Amyloid imaging is likely to find clinical utility in several fields, including the stratification of patients with mild cognitive impairment into those with and without underlying AD and the evaluation of atypical AD presentations. Conclusions: A number of recommendations and good practice points are made to improve the diagnosis of AD and other dementias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2012.03859.x

Cites

308 of 308 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 11

  1. [36]36. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol 2009; 8: 643-653.
  2. [72]72. Stein JL, Medland SE, Arias Vasquez A, et al. Com- mon genetic polymorphisms are associated with human hippocampal and intracranial volumes. Nat Genetics 2012; In press.
  3. [75]75. Devanand DP, Pradhaban G, Liu X, et al. Hippocam- pal and entorhinal atrophy in mild cognitive impair- ment: prediction of Alzheimer disease. Neurology 2007; 68: 828-836.
  4. [143]143. Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR. A voxel-based morphome- try study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neu- rol 2000; 47: 36-45.
  5. [172]172. Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cogni- tive impairment, Alzheimer's disease, and other demen- tias. J Nucl Med 2008; 49: 390-398.
  6. [186]186. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzhei- mer's disease? Neurology 2003; 60: 1374-1377.
  7. [201]201. Lim SM, Katsifis A, Villemagne VL, et al. The 18F- FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 2009; 50: 1638-1645.
  8. [207]207. Hilker R, Thomas AV, Klein JC, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 2005; 65: 1716- 1722.
  9. [230]230. Lee JH, Kim SH, Kim GH, et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 2011; 77: 18-25.
  10. [243]243. Kemppainen NM, Aalto S, Wilson IA, et al. PET amy- loid ligand [11C]PIB uptake is increased in mild cogni- tive impairment. Neurology 2007; 68: 1603-1606.
  11. [280]280. Kantarci K, Petersen RC, Boeve BF, et al. 1H MR spectroscopy in common dementias. Neurology 2004; 63: 1393-1398.

Cited by

Sorted by citations

Authors
Filippi, M., Agosta, F., Barkhof, F., Dubois, B., Fox, N. C., Frisoni, G. B., Jack, C. R., Johannsen, P., Miller, B. L., Nestor, P. J., Scheltens, P., Sorbi, S., Teipel, S., Thompson, P. M., & Wahlund, L. ‐.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Institut du Cerveau (FR)
  • UCL Queen Square Institute of Neurology (GB)
  • Centro San Giovanni di Dio Fatebenefratelli (IT)
  • Mayo Clinic (US)
  • Copenhagen University Hospital (DK)
  • University of California, San Francisco (US)
  • University of Cambridge (GB)
  • Azienda Ospedaliero-Universitaria Careggi (IT)
  • German Center for Neurodegenerative Diseases (DE)
  • University of California, Los Angeles (US)
  • Karolinska Institutet (SE)
Corresponding author
Filippi, M.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2012-08-20
Volume
19
Issue
12
Pages
1487-1501
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2084706106
Cited by
141
References
308
Citations by year
2026: 2 · 2025: 10 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 9 · 2020: 12 · 2019: 15 · 2018: 11 · 2017: 11 · 2016: 5 · 2015: 14 · 2014: 11 · 2013: 8 · 2012: 3
FWCI
8.18
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • Sanofi
  • Biogen
  • Teva Pharmaceutical Industries
  • Fondazione Italiana Sclerosi Multipla
  • BioClinica
  • National Institute for Health and Care Research (NF-SI-0508-10123)
  • University of Cambridge
  • Ministero della Salute
  • Eisai
  • H. Lundbeck A/S
  • Serono Symposia International Foundation
  • National Institutes of Health
  • Medical Research Council
  • National Institute on Aging (P01AG019724)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
neuroimaging, dementia diagnosis, Alzheimer's disease, non-Alzheimer's dementia, structural imaging, functional imaging, amyloid imaging, mild cognitive impairment, vascular lesions, neurodegenerative dementia
MeSH terms
Alzheimer Disease, Dementia, Humans, Advisory Committees, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review